banner

Latest News

Evonetix can be as big as Solexa, says Hauser

A recent article in Business Weekly on Evonetix: Dr Hauser, who has supported the company from birth, says: “Evonetix will do to gene-synthesis what Solexa did to gene-sequencing – revolutionise it. “There has been an architectural breakthrough which allows Evonetix to produce base-accurate genes of any length at a cost and speed that is orders of magnitude cheaper and faster than ...

Read More

Aspect Biosystems CEO Tamer Mohamed Named to Top 40 Under 40

A recent article on Aspect Biosystems CEO: We are proud to announce that our CEO Tamer Mohamed has been selected by Business in Vancouver for their annual Forty Under 40 Awards. These awards highlight the achievements of 40 of British Columbia's outstanding young entrepreneurs, executives, and professionals. All winners are under 40 years old and have demonstrated excellence in...

Read More

Start-up working on breakthrough in 3-D printing of human organs

A recent article on Prellis Biologics raising $1.8 million in new seed funding: Prellis Biologics, a human tissue engineering company, has invented a new way to create what it says are viable human organs using near instantaneous 3-D printing. This type of development, if proven out, could be a boon for hospitals and health systems with long lists of patients waiting for donor ...

Read More

Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq

A recent article on Rocket Pharmaceuticals merger announcement: Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to o...

Read More

Aspect Bio: Printed human body parts could soon be available for transplant

A recent article in the Economist on Aspect Bio: EVERY year about 120,000 organs, mostly kidneys, are transplanted from one human being to another. Sometimes the donor is a living volunteer. Usually, though, he or she is the victim of an accident, stroke, heart attack or similar sudden event that has terminated the life of an otherwise healthy individual. But a lack of suitable...

Read More

Cigna leads Omada Health’s latest $50M investment round

A recent article in Med City News on Omada Health investment: Omada, which has a built a digital platform to prevent prediabetics from becoming full-blown Type 2 diabetes patients, announced Wednesday that Cigna led its $50 million round that also attracted two new investors: Civilization Ventures and Sanofi Genzyme BioVentures. Cigna is doing more than just investing in Omada. It ...

Read More

Omada Health Raises $50 Million, Led by Cigna

Omada Health press release on $50m funding round:Two Companies Growing Commercial Collaboration to Deliver Chronic Disease Prevention to Cigna Members, Drive Innovation San Francisco, CA; Bloomfield, CT (June 14, 2017) – Building on the largest enrollment quarter in the company’s history, Omada Health today announced a $50 million fundraising round led by global health services leader Cigna ...

Read More

Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge

A recent article on Pillo Health: Boston Scientific Corporation (NYSE: BSX) today announced six finalists in its second annual Connected Patient Challenge, an open competition focused on turning big data into actionable intelligence that optimizes patient care and healthcare efficiency. "We were truly encouraged by the level of engagement by emerging developers and healthcare pract...

Read More

Engineered bacteria produce rare and commercially useful compounds in large quantities

A recent article in the MIT News discusses the potential of Manus Bio. Using advanced fermentation technology, industrial biotech startup Manus Bio hopes to make manufacturing flavors, fragrances, and other products greener and more cost-effective — and maybe create new products in the process. The MIT spinout has created a low-cost process for engineering microbes with comple...

Read More

Can a digital health startup prevent diabetes in Medicaid patients?

A recent article on Omada Health: At the headquarters of Omada Health, the exposed ceiling, stocked kitchen, and MacBook-toting millennials evoke the industrial-chic feel of a tech startup. One conference room here is named Kale, another Broccoli. Many employees have waistlines as thinly cut as their Levi’s. But the digital health company is at work on an experiment involving a ...

Read More